Loading Now

Cote d’Ivoire Ensures Continuity of HIV/AIDS Care Amid U.S. Aid Suspension

The Ivorian Ministry of Health has confirmed that care for HIV/AIDS will remain uninterrupted despite the recent suspension of U.S. funding announced by President Trump. The ministry stated that current supplies of antiretrovirals are sufficient, and measures are in place to prevent shortages. Cote d’Ivoire has made significant progress in reducing mortality related to HIV/AIDS while maintaining treatment access for approximately 400,000 patients.

In early February, U.S. President Donald Trump announced the closing of the U.S. Agency for International Development (USAID), which had pledged $115 million in assistance for Cote d’Ivoire in 2024, where HIV/AIDS treatment has been free since 2008. Despite this suspension of funding, the Ivorian Ministry of Health has assured that care for individuals living with HIV will remain “fully guaranteed.”

The ministry addressed public concerns regarding potential shortages of antiretrovirals (ARVs) due to U.S. aid cuts, emphasizing, “The care for HIV/AIDS is ensured and will continue to be.” They confirmed that there will be no disruption in the supply of ARVs, and a contingency plan was swiftly implemented to ensure uninterrupted treatment for those affected.

The government has reaffirmed its commitment to HIV/AIDS treatment, stating that current ARV stocks can support treatments for an estimated four months. A comprehensive monitoring system is also in place to prevent any shortages. “A financing mechanism has been activated to mitigate the impact of the suspension of external funding,” the committee noted.

Cote d’Ivoire has reported approximately 400,000 individuals living with HIV. Since 2010, the nation has successfully achieved a 70 percent decrease in HIV/AIDS-related mortality and has seen a decline in prevalence from 2.4 percent in 2020 to 1.8 percent in 2024. This progress underscores the effectiveness of the country’s ongoing efforts in combating the disease, even in light of external funding challenges.

In conclusion, while the recent suspension of U.S. funding raises concerns, Cote d’Ivoire’s Ministry of Health has reassured that the care and treatment for individuals living with HIV/AIDS will continue uninterrupted. The government’s proactive measures, including contingency plans and a financing mechanism, highlight a strong commitment to maintaining essential health services and ensuring that the progress against HIV/AIDS remains steadfast in the country.

Original Source: eastleighvoice.co.ke

Post Comment